Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

Shift work was associated with an increased risk for circadian syndrome but not metabolic syndrome among adults, especially those with evening work.

Users can check their hearing by taking the hearing test on their iPhone or iPad. The Food and Drug Administration (FDA) has cleared the Hearing Aid Feature (HAF), the first over-the-counter (OTC) ...